HELP ▲ +3.2% - Helus Pharma Inc
$HELP - Helus Pharma to Present Topline Results from Phase 3 APPROACH Study Evaluating HLP003 as Adjunctive Treatment in Major Depressive Disorder on November 16, 2026
15-NOV-2026 12:00 PM ET
Share this post
More filings for $HELP
HELP ▲ +2.2% - Cybin D/B/A Helus PharmaNov 3, 2026HELP ▲ +0.1% - Cybin D/B/A Helus PharmaOct 27, 2026HELP ▼ -2.7% - Cybin D/B/A Helus PharmaOct 21, 2026HELP ▼ -0.2% - Cybin D/B/A Helus PharmaOct 15, 2026HELP ▲ +0.4% - Cybin D/B/A Helus PharmaOct 8, 2026HELP ▲ +1.8% - Cybin D/B/A Helus PharmaOct 1, 2026
View full $HELP filing history →💬 Comments
Loading comments…
Leave a comment